Navigation Links
World Biotech API Market Potential Examined in New Topical Study Now Available at MarketPublishers.com
Date:6/20/2012

London, UK (PRWEB) June 20, 2012

The global API market has been advancing at a significant growth rate in recent times and it is likely to register a healthy CAGR of around 8% during 2012-2015, supported by factors such as emergence of India and China as prominent API manufacturing hub, patent expiration of blockbuster drugs and technological innovation to drive HPAPI segment, as well as impressive participation of private players.

Biotech APIs have a very low share in the global API market with synthetic APIs accounting for majority of the formulations. However, with the revolutionary growth in the biopharmaceutical industry and gaining applications of biotech drugs, biotech APIs are sure to see a highly prospective market in the future. The branded APIs currently dominate the biotech APIs market; however, with growing patent expiries and advancements in the market structure, the generic APIs will see a rapid growth.

New market research study “Global Biotech API Market Analysis” elaborated by RNCOS E-Services has been recently published by Market Publishers Ltd.

Report Details:

Title: Global Biotech API Market Analysis
Published: June, 2012
Pages: 60
Price: US$ 1,000.00
http://marketpublishers.com/report/medicine_pharmaceuticals_biotechnology/drugs_biotechnology/global_biotech_api_market_analysis.html

The study presents unbiased analysis and forecast for the biotech API market from a global perspective. It analyses the regulatory structure in the API and the biotech API market covering the mandates and guidelines for manufacturing, safety, and good manufacturing practices (GMP). The report also provides elaborate profiles the top companies involved in the biotech API business to gain insights on their overall business, biotech API functioning, recent activities, along with analysis of their strengths and weaknesses. Furthermore, prudent market segmentation and forecasts; the geographic analysis and regulatory overview can also be found in the review.

Companies discussed include: Bayer Pharma AG, Bayer Pharma AG, Boehringer Ingelheim, Hospira, Lonza, Ranbaxy Laboratories, Royal Dsm N.V., Sigma-Aldrich, Teva Active Pharmaceutical Ingredients, Zhejiang Hisun Pharmaceutical Co. Ltd.

Report Contents:

1. Analyst View

2. Research Methodology

3. Biotech Active Pharmaceutical Ingredients - an Introduction

4. Active Pharmaceutical Ingredient - Industry Performance

4.1 Current and Future Market Analysis to 2015
4.2 Branded and Generic APIs
4.3 Synthetic and Biotech APIs

5. Biotech Active Pharmaceutical Ingredients - Industry Performance

5.1 Current and Future Market Analysis to 2015
5.2 Biogeneric and Innovator Biotech APIs
5.3 Key Geographical Markets

6. Regulatory Environment

7. Competitive Landscape

7.1 Bayer Pharma AG
7.1.1 Business Overview
7.1.2 Strengths and Weaknesses
7.1.3 Recent Developments
7.2 Biocon Limited
7.2.1 Business Overview
7.2.2 Strengths and Weaknesses
7.2.3 Recent Developments
7.3 Boehringer Ingelheim
7.3.1 Business Overview
7.3.2 Strengths and Weaknesses
7.3.3 Recent Developments
7.4 Hospira
7.4.1 Business Overview
7.4.2 Strengths and Weaknesses
7.4.3 Recent Developments
7.5 Lonza
7.5.1 Business Overview
7.5.2 Strengths and Weaknesses
7.5.3 Recent Developments
7.6 Ranbaxy Laboratories
7.6.1 Business Overview
7.6.2 Strengths and Weaknesses
7.6.3 Recent Developments
7.7 Royal Dsm N.V.
7.7.1 Business Description
7.7.2 Strengths and Weaknesses
7.7.3 Recent Developments
7.8 Sigma-Aldrich
7.8.1 Business Overview
7.8.2 Strengths and Weaknesses
7.8.3 Recent Developments
7.9 Teva Active Pharmaceutical Ingredients
7.9.1 Business Overview
7.9.2 Strengths and Weaknesses
7.9.3 Recent Developments
7.10 Zhejiang Hisun Pharmaceutical Co. Ltd.
7.10.1 Business Overview
7.10.2 Strengths and Weaknesses
7.10.3 Recent Developments

List of Figures:

Figure 4-1: Global - API Market (Billion US$), 2011-2015
Figure 4-2: Global - Share of Captive and Merchant Market in API Market (2011)
Figure 4-3: Global - Share of Branded and Generic APIs in API Merchant Market (2011)
Figure 4-4: Global - Share of Synthetic and Biotech APIs in API Market (2011)
Figure 5-1: Global - Biotech API Market (Billion US$), 2011-2015
Figure 5-2: Global - Share of Biogeneric and Innovator APIs in Biotech API Market by (2011)
Figure 5-3: Global - Biotech API Market by Country (%), 2011

More new market research reports by the publisher can be found at RNCOS E-Services page.

Read the full story at http://www.prweb.com/releases/2012/6/prweb9623005.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Plasma etching pushes the limits of a shrinking world
2. Researching graphene nanoelectronics for a post-silicon world
3. Multidisciplinary team of researchers develop world’s lightest material
4. Hologic to Showcase 3D Mammography (Breast Tomosynthesis) and Other Advanced Womens Imaging Technologies at RSNA 2011, the Largest Radiology Show in the World
5. Researchers develop one of the worlds smallest electronic circuits
6. Janssen Biotech, Inc. Announces Collaborative Development and Worldwide License Agreement for Investigational Anti-Cancer Drug, PCI-32765
7. Experts Launch the Alliance for Fertility Preservation at the International Society for Fertility Preservations 2nd World Congress
8. The worlds smallest steam engine
9. StemCyte Adds World Class Talent to its North America and Global Operations
10. West Palm Beach, FL to Host 8th Annual World Stem Cell Summit December 3-5, 2012
11. U of Toronto experiment named top breakthrough of 2011 by Physics World
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)...  Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the ... and commercializing products to treat rare diseases where ... the long-term follow-up data from its Phase 2 ... Defense Regulator (IDR), in the treatment of oral ... undergoing chemoradiation therapy (CRT).  The additional 12-month safety ...
(Date:12/8/2016)... 8, 2016 Savannah River Remediation LLC ... selected NewTechBio,s NT-MAX Lake & Pond Sludge ... bacteria, in conjunction with Hexa Armor/ Rhombo cover ... National Pollutant Discharge Elimination System requirements. ... steady history of elevated pH levels, above 8.5, ...
(Date:12/8/2016)... SAN DIEGO , Dec. 8, 2016 /PRNewswire/ ... ), a leading commercial provider of clinically actionable ... cancer patients, announces that clinical data featuring its ... concordance to tissue biopsy for the detection of ... The results from research sponsored by Sara Cannon ...
(Date:12/7/2016)... ... December 07, 2016 , ... Huffman Engineering, Inc. , ... Wonderware Certified System Integrator Partner. Huffman Engineering is the only Nebraska-based company ... System Integrator Partner certification gives customers confidence that our engineers are fully trained ...
Breaking Biology Technology:
(Date:12/2/2016)... , Dec. 1, 2016   SoftServe ... announced BioLock , an electrocardiogram (ECG) biosensor ... monitoring, a key IoT asset. The smart system ... a vehicle,s steering wheel and mobile devices to ... touch. As vehicle technology advances, so ...
(Date:11/29/2016)... 2016   Neurotechnology , a provider ... technologies, today released FingerCell 3.0, a software ... that run on low-power, low-memory microcontrollers. FingerCell ... than 128KB of memory, enabling it to ... limited on-board resources, such as: mobile phones, ...
(Date:11/22/2016)... India , November 22, 2016 According to ... (Fingerprint, IRIS, Palm Print, Face, Vein, Signature, Voice), Multi-Factor), Component (Hardware and ... 2022", published by MarketsandMarkets, the market is expected to grow from USD ... a CAGR of 16.79% between 2016 and 2022. ... ...
Breaking Biology News(10 mins):